Hjem
Rolf Bjerkvigs bilde

Rolf Bjerkvig

Professor
  • E-postRolf.Bjerkvig@uib.no
  • Telefon+47 55 58 63 52+47 951 18 268
  • Besøksadresse
    Jonas Lies vei 91
  • Postadresse
    Postboks 7804
    5020 Bergen

Rolf Bjerkvig (f. 1953) er professor for cellebiologi og har siden 80tallet jobbet i eksperimentell kreftbiologi.

Bjerkvig er direktør for Senter for Hjernekreft, som ligger ved Institutt for biomedisin. Han er direktør for Institutt for onkologi ved Luxembourg Institute of Health, og har etablert NORLUX Neuro-Oncology-nettverket.

I 2015 ble Bjerkvig tildelt kong Olav V kreftforskningsprisen.

 

 

OD1ANA - Anatomi

MEDOD1, MEDOD2

MEIBM900

FARM260 - Molekylær cellebiologi

BMED330 - Cellekommunikasjon

BMED331 - Tumorbiologi

 

  • Vis forfatter(e) 2020. Tumor-penetrating peptide for systemic targeting of Tenascin-C. Scientific Reports.
  • Vis forfatter(e) 2020. Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospects. Neuro-Oncology Advances (NOA).
  • Vis forfatter(e) 2020. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology. Acta Neuropathologica. 1-31.
  • Vis forfatter(e) 2020. Identification of a Blood-Based Protein Biomarker Panel for Lung Cancer Detection. Cancers.
  • Vis forfatter(e) 2020. AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion. Nature Communications.
  • Vis forfatter(e) 2019. Targeting APLN/APLNR improves antiangiogenic efficiency and blunts proinvasive side effects of VEGFA/VEGFR2 blockade in glioblastoma. Cancer Research. 2298-2313.
  • Vis forfatter(e) 2019. Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma. Neuro-Oncology. 890-900.
  • Vis forfatter(e) 2019. Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis. Acta neuropathologica communications. 1-19.
  • Vis forfatter(e) 2019. Deciphering the complex role of thrombospondin-1 in glioblastoma development. Nature Communications. 1-15.
  • Vis forfatter(e) 2019. Blood brain barrier opening and Therapeutic Effect of Free and Nanoencapsulated Cabazitaxel in an Invasive Patient-Derived Glioblastoma Model.

Se fullstendig oversikt over publikasjoner i CRIStin.

1987: Dr. philos. The Gade Institute of Pathology, University of Bergen

1981: M.Sc. Immunology, University of San Francisco, 1981.